BOLD - Audentes Therapeutics' (BOLD) CEO Matt Patterson on Q1 2019 Results - Earnings Call Transcript
Audentes Therapeutics , Inc. (BOLD)
Q12 2019 Results Earnings Conference Call
May 7, 2019 4:30 PM ET
Company Participants
Andrew Chang – Head-Investor Relations
Matt Patterson – Chairman and Chief Executive Officer
Conference Call Participants
Anupam Rama – J.P. Morgan
Nicole Gabreski – Piper Jaffray
Aspen Mori – Bank of America Merrill Lynch
Dae Ha – SVB Leerink
Ritu Baral – Cowen
Whitney Ijem – Guggenheim Securities
Debjit Chattopadhyay – H.C. Wainwright
Raju Prasad – William Blair
Alex Lim – Mizuho
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the Audentes Therapeutics’ First